Bioinformatics News Feb 2007: bioinformatics, genomics, proteomics, microarray, etc.

Previous 1 2 3 4

Subscribe to Genome Technology Magazine Today – FREE to Active Researchers.
Request a subscription before March 1 and download the February Translational Medicine issue right away at no charge. (Thu, 22 Feb 2007 15:36:03 GMT)

Easley proposes $20.1 billlion budget
Gov. Mike Easley proposed a $20.1 billion budget today that would cut taxes for the state's poorest residents and offer online college courses for high schoolers. That is a 6.4 percent increase from last year's approved budget. (Thu, 22 Feb 2007 17:38:54 GMT)

CCR increases power, synergy with researchers
Over the past year, UB's Center for Computational Research has quadrupled computing power, upgraded its high-performance storage system and installed a new state-of-the-art visualization room. (Thu, 22 Feb 2007 17:58:54 GMT)

UB research receives NYSTAR funding
A UB medicinal chemist has identified compounds to target a ribonucleic acid (RNA) that causes a form of muscular dystrophy called myotonic dystrophy, or DM. (Thu, 22 Feb 2007 17:59:36 GMT)

Compendia Bioscience and Ingenuity Systems Partner to Integrate Cancer Gene Signature Data With Network Analysis Tools
Compendia Bioscience, Inc.(TM), the leading provider of cancer profiling data and analysis tools, and Ingenuity Systems(R), the leading provider of software and data bases for biological exploration, interpretation, and analysis, today announced the integration of their flagship products Oncomine(TM) Professional and Ingenuity Pathways Analysis. (Thu, 22 Feb 2007 18:25:33 GMT)

Killing the messenger RNA -- But which one?
(PHILADELPHIA) -- Tiny molecules called microRNAs, only 19 to 21 nucleotides in length, are able to effectively silence sometimes large sets of genes. (Thu, 22 Feb 2007 19:12:27 GMT)

Small Gene-Silencing Molecules Subject to Redirection by Editing
Tiny molecules called microRNAs are able to effectively silence large sets of genes. They do this by specifically binding to and neutralizing another form of RNA called messenger RNA. Now, a new study shows that microRNAs can undergo a kind of molecular editing, and a single substitution in their sequence can redirect them to silence entirely different sets of genes from their unedited ... (Thu, 22 Feb 2007 19:15:44 GMT)

Easley's $20.1B budget ups education spending, cuts income tax for some
North Carolina Gov. Mike Easley's $20.1 billion budget proposal for 2007-2009 would increase education spending in the state to $11.6 billion, up nearly 8 percent over his previous budget proposal. (Thu, 22 Feb 2007 19:48:22 GMT)

Expression Analysis Relocates to Larger Laboratory Facility while Expanding its Genomic Services and Staff
DURHAM, N.C.----Expression Analysis, Inc., the industry's leading provider of Affymetrix GeneChip® brand microarray services for clinical trials, announced today that it has relocated its GLP-compliant laboratory to a larger facility in Durham, NC. (Thu, 22 Feb 2007 20:32:00 GMT)

2,000 Influenza Virus Genomes Now Completed And Publicly Accessible
The Influenza Genome Sequencing Project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), announced today that it has achieved a major milestone. The entire genetic blueprints of more than 2,000 human and avian influenza viruses taken from samples around the world have been completed and the sequence data made available ... (Thu, 22 Feb 2007 22:11:37 GMT)

NIH: 2,000 flu viruses sequenced, data published
Feb 22, 2007 (CIDRAP News) – Scientists with the National Institutes of Health (NIH) have finished mapping the genomes of more than 2,000 human and avian influenza viruses, an achievement that will help efforts to develop new flu vaccines and drugs, the NIH said yesterday. (Thu, 22 Feb 2007 23:10:46 GMT)

Gore to expand to Phoenix
W.L. Gore & Associates plans a major expansion in Phoenix. It will keep adding jobs in Flagstaff, too. (Fri, 23 Feb 2007 04:02:34 GMT)

Biotech IPOs' Iffy Prognosis
Many biotechs' initial public offerings are serving as a cash injection for drug development efforts rather than a payday for investors (Fri, 23 Feb 2007 04:58:38 GMT)

Harvard and Humanities
After a scarred tenure of missteps and controversial speeches - including one in which he said genetic differences between men and women may account for the relatively low number of women in top academic science positions - Harvard University President Larry Summers stepped down from his post last year, paving the way for a long, secretive search process that culminated in the hiring of the ... (Fri, 23 Feb 2007 07:11:15 GMT)

Killing The Messenger RNA: Small Gene-Silencing Molecules Subject To Redirection By Editing
Tiny molecules called microRNAs are able to effectively silence large sets of genes. They do this by specifically binding to and neutralizing another form of RNA called messenger RNA. Now, a new study shows that microRNAs can undergo a kind of molecular editing, and a single substitution in their sequence can redirect them to silence entirely different sets of genes from their unedited ... (Fri, 23 Feb 2007 07:12:56 GMT)

Gore to expand to Phoenix
W.L. Gore & Associates plans a major expansion in Phoenix. It will keep adding jobs in Flagstaff, too. (Fri, 23 Feb 2007 08:36:49 GMT)

Gene Logic Reports Fourth Quarter and Full Year 2006 Financial Results
GAITHERSBURG, Md.----Gene Logic Inc. today reported financial results for the fourth quarter and twelve months ended December 31, 2006. (Fri, 23 Feb 2007 11:00:00 GMT)

Acacia Technologies Acquires Rights to Patent Portfolio for Storage Technology
NEWPORT BEACH, Calif., BUSINESS WIRE -- Acacia Research Corporation (Nasdaq:ACTG)(Nasdaq:CBMX) announced today that Acacia Patent Acquisition Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has acquired rights to a patent portfolio relating to storage technology. (Fri, 23 Feb 2007 12:23:11 GMT)

Ciphergen Reports Fourth Quarter and Year-End 2006 Financial Results and Provides Milestones For 2007
Ciphergen Biosystems, Inc. today announced financial results for its fourth quarter and year ended December 31, 2006. (Fri, 23 Feb 2007 13:00:00 GMT)

Colorado Bioscience Association Showcases the State’s Most Promising Technologies
Colorado research institutions have begun reaping the rewards of legislation allocating state funds for bioscience research. HB 1360, sponsored by Representative Jim Reisberg (D-Greeley) and Senator Ron Tupa (D-Boulder), was signed into law by Governor Bill Owens last summer. $2 million in state funds was awarded to 27 bioscience proof of concept projects at six Colorado universities and research ... (Fri, 23 Feb 2007 14:01:15 GMT)

Scientists Use Nanoparticle To Discover Disease-causing Proteins
A complex molecule and snake venom may provide researchers with a more reliable method of diagnosing human diseases and developing new drugs. (Fri, 23 Feb 2007 14:44:28 GMT)

Killing The Messenger RNA -- But Which One?
Tiny molecules called microRNAs, only 19 to 21 nucleotides in length, are able to effectively silence sometimes large sets of genes (Fri, 23 Feb 2007 15:23:18 GMT)

Strategic Diagnostics to Report Fourth Quarter and Fiscal Year 2006 Results on March 1, 2007
Strategic Diagnostics Inc. a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, expects to release its fourth quarter and fiscal year 2006 results at approximately 4 p.m. (Fri, 23 Feb 2007 15:28:00 GMT)

Gene Logic Could Spin Off Genomics Unit as Review Continues; Q4 Revenues Slide 60 Percent
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 23 Feb 2007 15:36:12 GMT)

Biotech, pharma stocks drift into negative territory
BOSTON (MarketWatch) - Biotech and pharmaceutical stocks drifted into negative territory early Friday, with Gene Logic Inc. being a notable early decliner. (Fri, 23 Feb 2007 15:40:40 GMT)

Fatty tears help dry eyes
People have obsessed about fat in their thighs, arms and abs for years, but researchers at Ohio State have discovered fat in the most peculiar place: the eyeball. (Fri, 23 Feb 2007 16:02:35 GMT)

Ciphergen Reports Fourth Quarter and Year-End 2006 Financial Results and Provides Milestones For 2007
FREMONT, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. today announced financial results for its fourth quarter and year ended December 31, 2006. "In 2006, we successfully restructured and repositioned Ciphergen. (Fri, 23 Feb 2007 16:19:37 GMT)

Expression Analysis moves to new HQ
Genomics testing firm Expression Analysis on Friday said it has shifted its headquarters to a new, larger facility in Durham. (Fri, 23 Feb 2007 17:58:11 GMT)

Schumer tours Cornell's Technology Farm in Geneva
U.S. Sen. Charles Schumer toured Cornell's Agriculture and Food Technology Park in Geneva Feb. 22, where he discussed new research in grape genomics and pitched a plan to improve education in math and science nationwide. (Fri, 23 Feb 2007 18:08:44 GMT)

Ciphergen narrows Q4, 2006 loss
Ciphergen Biosystems Inc. cut its fourth-quarter loss following the sale of its life sciences business to Bio-Rad Laboratories Inc., the company reported Friday. (Fri, 23 Feb 2007 18:44:15 GMT)

Acacia Technologies Licenses Fraud Protection Technology to Outspoke Technologies
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that Credit Card Fraud Control Corporation, a wholly owned subsidiary of the Acacia Technologies group, a leader in technology licensing, has entered into a non-exclusive license with Outspoke Technologies, Inc. and its affiliates covering a patent that applies to fraud protection technology. (Fri, 23 Feb 2007 22:33:00 GMT)

Acacia Technologies Licenses Fraud Protection Technology to Outspoke Technologies
NEWPORT BEACH, Calif., (Fri, 23 Feb 2007 23:23:14 GMT)

Mayo researcher under investigation by FBI
A research scientist and associate professor of medicine at the Mayo Clinic in Rochester is under investigation by the FBI for purchasing potassium cyanide for use as "a chemical weapon" in connection with a domestic dispute, according to a federal search warrant unsealed this week in St. Paul. According to a sworn affidavit filed by the FBI, the matter came to light when Rochester police ... (Sat, 24 Feb 2007 05:38:22 GMT)

Researchers Find Genes Involved In Nicotine Resistance In Fruit Flies
North Carolina State University researchers have gleaned insight into the genes involved in resistance to nicotine in the lab rat of many gene studies -- Drosophila melanogaster, the fruit fly. (Sat, 24 Feb 2007 15:20:04 GMT)

Initial public offerings
The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, Conn. (www.ipohome.com), and SEC filings. (Sun, 25 Feb 2007 11:56:11 GMT)

Two Cancer Research IPOs: Rosetta Genomics, OncoGenex Tech
Abbi Adest submits: Two biotech companies focused on different aspects of cancer treatment are going public this week: Rosetta Genomics , an early stage company developing new cancer treatments based on microRNAs; and OncoGenex Technologies , a pharmaceutical company working on products that reduce treatment resistance of cancer cells. (Sun, 25 Feb 2007 19:13:56 GMT)

Nicotine no better for flies than humans
RALEIGH - Nicotine seems to be a dangerous addiction whether you're human or a fruit fly. (Sun, 25 Feb 2007 22:03:04 GMT)

News Summary
Maryland Sens. Benjamin L. Cardin and Barbara A. Mikulski on Friday announced that the Baltimore Central Light Rail will receive a grant of more than $12.1 million toward final federal funding to double-track the system. (Mon, 26 Feb 2007 00:45:51 GMT)

Response to Drugs: It's All in the Genes
By Dr Zilfalil Bin Alwi When Pakcik Ali was told by his family doctor that he was suffering from hypertension, he was put on a drug called metoprolol, a commonly available anti-hypertensive drug. This drug is the first- line treatment in most government hospitals. (Mon, 26 Feb 2007 03:32:26 GMT)

Stock Offerings This Week
The following equity and convertible debt offerings are expected this week:. (Mon, 26 Feb 2007 04:32:22 GMT)

Graffinity and Amgen Enter into Drug Discovery Research Agreement
HEIDELBERG, Germany----Graffinity Pharmaceuticals GmbH announced today that it has entered into a research collaboration with Amgen, Thousand Oaks, California. Under the terms of the agreement, Graffinity will receive technology access fees and success payments for the generation of novel small molecule hits against a broad range of drug targets. (Mon, 26 Feb 2007 06:00:00 GMT)

IPO's planned
These initial public offerings are planned for this week, according to Renaissance Capital and SEC filings: OncoGenex Technologies Inc., Vancouver, B.C.: 4.5 million shares, priced $10 to $12, managed by RBC Capital Markets. Proposed Nasdaq symbol OGXI. Business: Developing treatments to reduce tumor cells' resistance to cancer therapies. (Mon, 26 Feb 2007 08:08:04 GMT)

Biotage AB and McMaster University Sign Joint Agreement to Develop New Chemistry Platform to Speed the Production of ...
STOCKHOLM, Sweden----As part of the agreement, Biotage will provide funding and instruments, including an Initiator microwave synthesizer, SP4 flash purification system, and V10 Evaporator. (Mon, 26 Feb 2007 09:59:00 GMT)

Convention Calendar
Today: * Intermountain Harvesting Energy Network Utah State Fairpark/Courtyard by Marriott Planned attendance: 300 Runs through: Wednesday * Public Hospital Pharmacy Coalition Hilton SLC Center Planned attendance: 400 Runs through: Wednesday (Mon, 26 Feb 2007 10:38:44 GMT)

Acacia Technologies Licenses Credit Card Fraud Protection Technology to Travelex America
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that Financial Systems Innovation LLC, a wholly owned subsidiary of the Acacia Technologies group, a leader in technology licensing, has entered into non-exclusive licenses covering a patent that applies to credit card fraud protection technology with Travelex America Holdings, Inc. (Mon, 26 Feb 2007 11:00:00 GMT)

Bruker Daltonics Exhibits New Life-Science Mass Spectrometry and Chemical Detection Products and Major Solution ...
CHICAGO----At Pittcon 2007, Bruker Daltonics today introduces numerous novel products to further enhance its life-science mass spectrometry solutions and its chemical detection product line: The newly-launched apex®-ultra sets a new standard for high-performance FTMS in top-down proteomics and complex mixture analysis. (Mon, 26 Feb 2007 11:30:00 GMT)

IR BioSciences Holdings, Inc. to Collaborate with Leading Clinical Services Company to Evaluate Radilex(TM) in ...
ImmuneRegen BioSciences, a wholly owned subsidiary of IR BioSciences Holdings, Inc. announced today that it has entered into an agreement with The Translational Genomics Research Institute , a non- profit organization focused on developing earlier diagnostics and smarter treatments. (Mon, 26 Feb 2007 12:00:00 GMT)

Stellar Pharmaceuticals Announces John Gregory, Founder of King Pharma and Stellar's Largest Shareholder, Has Joined ...
LONDON, Ontario----Stellar Pharmaceuticals Inc. , a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced that Mr. (Mon, 26 Feb 2007 12:30:00 GMT)

Stellar Pharmaceuticals Announces John Gregory Founder of King Pharma and Stellar's Largest Shareholder Has Joined the ...
Stellar Pharmaceuticals Inc.(OTC.BB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced that Mr. (Mon, 26 Feb 2007 12:30:00 GMT)

Varian, Inc. Introduces New High Performance FTMS Systems
Varian, Inc. announced today its new 900-MS series Fourier Transform mass spectrometers . (Mon, 26 Feb 2007 13:00:00 GMT)

NCSU Researchers Uncover Link to Nicotine Resistance
Editor’s note: WRAL Local Tech Wire is adding sources for news, including stories, photos and graphics produced by the news services of various universities. Such stories will be labeled as UniversityTech and with the appropriate source. (Mon, 26 Feb 2007 13:04:44 GMT)

Dr. Andrey Zarur Joins Kodiak Venture Partners
WALTHAM, Mass.----Dr. Andrey Zarur has joined Kodiak Venture Partners, a seed and early stage venture capital firm, as General Partner. Zarur will source deals and support Kodiak portfolio companies within the intersection of the healthcare and high technology markets. (Mon, 26 Feb 2007 13:30:00 GMT)

Acacia Technologies Licenses Credit Card Fraud Protection Technology to Travelex America
NEWPORT BEACH, Calif., (Mon, 26 Feb 2007 14:38:33 GMT)

TRADE NEWS: Agilent Technologies Expands Use of HPLC Chip to Entire LC Mass Spectrometry Portfolio
CHICAGO----Agilent Technologies today expanded use of its revolutionary, high-performance liquid chromatography chip to its triple quadrupole and quadrupole-time of flight mass spectrometers. (Mon, 26 Feb 2007 15:30:00 GMT)

Varian, Inc. Shows New Products at PITTCON(R) 2007
New information rich detection systems and laboratory consumables showcase Varian, Inc. technologies for solving important life science and chemical analysis challenges at the 2007 Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy . (Mon, 26 Feb 2007 16:00:00 GMT)

Rosetta Biosoftware Licenses the Rosetta Resolver(R) Gene Expression Data Analysis System to the University of ...
SEATTLE & LOS ANGELES----Rosetta Biosoftware announced today that the University of California, Los Angeles licensed the Rosetta Resolver® system to support research at UCLA's Jonsson Comprehensive Cancer Center . (Mon, 26 Feb 2007 16:00:00 GMT)

Biotech vet Zarur joins Kodiak
Waltham's Kodiak Venture Partners reports the appointment of Andrey Zarur as the firm's general partner identifying deals and supporting Kodiak portfolio companies that combine health care and technology. (Mon, 26 Feb 2007 16:06:23 GMT)

Stellar Pharmaceuticals Announces John Gregory Founder of King Pharma and Stellar's Largest Shareholder Has Joined the ...
Stellar Pharmaceuticals Inc. (TSX VENTURE: SLX)(OTCBB: SLXCF) ('Stellar' or 'the Company'), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced that Mr. John M. Gregory, RPH founder and former CEO of King Pharmaceuticals has agreed to join the Stellar board as a new director. John is the founder and managing ... (Mon, 26 Feb 2007 16:25:22 GMT)

Varian, Inc. Introduces New High Performance FTMS Systems
Varian, Inc. announced today its new 900-MS series Fourier Transform mass spectrometers (FTMS). Due to the ultra-high resolution (>500,000) and mass accuracy (<1 ppm), 900-MS series instruments are ideal for a variety of application areas including proteomics, metabolomics, petrochemical and environmental analyses. The flexibility of the 900-MS series instruments allows the user to switch from ... (Mon, 26 Feb 2007 17:08:15 GMT)

New Product Review
A line of sealing tapes is available for use with microtiter plates, microfluidic chips, and microarrays. These sealing tapes offer resistance to polar organic solvents, acids, and alcohols; high and low temperature resistance; and high optical properties for test detection. (Mon, 26 Feb 2007 18:35:38 GMT)

Metabolic Response to Colitis Varies Depending Upon Whether Inflammation Is Chronic Or Acute
A new study being published by the American Physiological Society (www.The-APS.org) finds that the body responds differently to colitis (inflammation of the colon) based on whether the disease is acute (sharp and brief) or chronic (long-term). (Mon, 26 Feb 2007 19:15:48 GMT)

DSRTF Announces $2 Million Fundraising Campaign for Down Syndrome Cognition Research
The Down Syndrome Research and TreatmentFoundation (DSRTF), a leading funder of Down syndrome cognition research,announced their fundraising target of $2 million for 2007 during theinaugural meeting of its Scientific Advisory Board (SAB). Citing theimportance of advances made quietly during the past five years, DSRTF ischallenging the medical research community to review both the science andthe ... (Mon, 26 Feb 2007 19:26:22 GMT)

Biotech Week in Review: Holding Steady
Centient Biotech Investor submits: For the third week in a row, biotech continued its Hamlet-like indecisiveness. The net change for each of the last three weeks has been under one-half of one percent. (Mon, 26 Feb 2007 20:07:54 GMT)

Stanford Genomics Lab Installs BioTrove's Genotyping Platform
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 26 Feb 2007 20:21:22 GMT)

Dr. Lawrence J. Fogel, Inventor of Evolutionary Programming, Dies at 78
Dr. Lawrence J. Fogel, an award-winning computer scientist, musician, model airplane and sailboat enthusiast, and pioneer in computational intelligence, died peacefully in San Diego on February 18, 2007 of complications from renal failure. (Mon, 26 Feb 2007 20:23:00 GMT)

IPOs
Initial public offerings planned for this week: (Mon, 26 Feb 2007 21:38:08 GMT)

Lean New Pharma
Big drug companies are moving in the right direction by scaling down and focusing on research. (Mon, 26 Feb 2007 23:00:27 GMT)

Calif., Boston Still Biotech Hubs, But Rest Of U.S. Wants A Share
When Pennsylvania funded the Pittsburgh Tissue Engineering Initiative in 1996, it hoped to build a regional biotechnology industry. (Tue, 27 Feb 2007 00:00:00 GMT)

Calif., Boston Still Biotech Hubs, But Rest Of U.S. Wants A Share
Bioscience has blossomed where steel-making once ruled. (Tue, 27 Feb 2007 00:00:00 GMT)

Is most published research really false?
In 2005, PLoS Medicine published an essay by John Ioannidis, called "Why most published research findings are false," that has been downloaded over 100,000 times and that was called "an instant cult classic" in a Boston Globe op-ed of July 27 2006 ( http://www.boston.com/news/sci ). This week, PLoS Medicine revisits the essay, publishing two articles by ... (Tue, 27 Feb 2007 01:05:35 GMT)

Invitrogen to Present at Lehman Brothers Tenth Annual Global Healthcare Conference
CARLSBAD, Calif.----Invitrogen Corporation , announced today that David F. Hoffmeister, Invitrogen's Chief Financial Officer, will present at the Lehman Brothers Tenth Annual Global Healthcare Conference in Miami, Florida, on Tuesday, March 20th, 2007. (Tue, 27 Feb 2007 01:10:00 GMT)

Genetic testing faces legal obstacles, doctors' limited expertise
Some predict doctors face the prospect of lawsuits for failing to order genetic tests when prescribing medicine. {b} Legal and ethical issues in biomedicine (Tue, 27 Feb 2007 03:47:48 GMT)

Celera Identifies Novel Genes Associated with Late-Onset Alzheimer's Disease
ROCKVILLE, Md.----Celera , an Applera Corporation business, today announced the publication of data from its research studies identifying several candidate genetic markers associated with late-onset Alzheimer's disease , including markers in multiple genes that have never been associated with LOAD. (Tue, 27 Feb 2007 12:00:00 GMT)

Acacia Technologies Expands Business Development Team
NEWPORT BEACH, Calif., BUSINESS WIRE -- Acacia Research Corporation (Nasdaq: ACTG: CBMX) announced today that David White has joined its Acacia Technologies group, a leader in technology licensing, as Vice President, Business Development. (Tue, 27 Feb 2007 12:23:23 GMT)

Rosetta Genomics Ltd. Announces Pricing of its Initial Public Offering
Rosetta Genomics Ltd. announced today that its initial public offering of 3,750,000 ordinary shares was priced at $7.00 per share. All shares are being sold by Rosetta Genomics. The shares will be listed on the Nasdaq Global Market under the symbol "ROSG" and will begin trading today. (Tue, 27 Feb 2007 13:00:00 GMT)

Rosetta Genomics Ltd. (ROSG) Founder and Chief Architect to Ring the NASDAQ Stock Market Closing Bell
ADVISORY, Feb. 27, 2007 -- (Tue, 27 Feb 2007 13:34:56 GMT)

Lipomics Technologies to Partner With UC Davis in Personalized Medicine Research
Lipomics Technologies, Inc., a privately held company that specializes in the analysis of lipid metabolites, announced today that it has entered into an agreement with The University of California, Davis to collaborate on research projects with an emphasis on personalized medicine. (Tue, 27 Feb 2007 14:00:00 GMT)

Agilent Technologies Launches Metabolomics Initiative With New Web Site And Customized METLIN Database
Agilent Technologies today announced a metabolomics initiative featuring a new Web site, the new Agilent METLIN Personal Database and a portfolio of metabolomics systems. The announcement underscores the company's commitment to accelerating metabolomics research (Tue, 27 Feb 2007 14:22:57 GMT)

Genedata Joins European Systems Biology Initiative BaSysBio
Swiss-based computational biology provider Genedata AG announces its participation in BaSysBio, an integrated systems biology project involving 15 research organizations from nine European countries (Tue, 27 Feb 2007 14:52:29 GMT)

Agilent Technologies Enhances MassHunter Software, Expands It To TOF Mass Spectrometer To Benefit Customers In All ...
Agilent Technologies announced that it has expanded applications and features of the Agilent MassHunter Workstation data processing software, enabling customers to save more time and obtain even more refined results (Tue, 27 Feb 2007 15:23:28 GMT)

More News
Revenues fell to $24.3 million from $57.2 million in 2005, its net loss widened to $54.7 million from $48.3 million in 2005 and it slashed its workforce from 434 to 151 employees, the company reported Friday. (Tue, 27 Feb 2007 15:50:09 GMT)

Eric and Kim Lund weigh options for the 2nd time in 3 years
For much of a pre-dinner conversation, Eric Lund speaks in short, to-the-point sentences about Pfizer's decision to leave Ann Arbor and the impact it will have on him and his wife, Kim. (Tue, 27 Feb 2007 16:01:07 GMT)

Sample Preparation in Lab-on-a-Chip Systems
Micro-total analysis systems (µTAS) or lab-on-a-chip systems (LoC) allow nonskilled people to perform complete and complex analyses, for example, for diagnostics or the detection of allergens, harmful bacteria and toxic substances. (Tue, 27 Feb 2007 16:55:48 GMT)

GeneGo Launches 'Pay-As-You-Go' 1-2-3 Workflow(TM) at the Molecular Medicine Tri-Conference
GeneGo, Inc., the leading systems biology tools company, announced today the release of a new product, 1-2-3 Workflow(TM), accessible via a 'pay-as-you-go' model. This easy to use workflow provides casual users with an automated comprehensive functional analysis of multiple gene lists in just two clicks. All the processing is done in the background and the customers receive a report in a ... (Tue, 27 Feb 2007 17:01:43 GMT)

Star-P Helps MIT Researchers Visualize Drug Effects
Researchers in MIT's Computational and Systems Biology Initiative (CSBi) are using Interactive Supercomputing Inc.'s (ISC) Star-P(TM) software to create new biological models that may someday yield new drug discoveries. (Tue, 27 Feb 2007 18:01:39 GMT)

Record $6.2 million grant awarded to MSU's Jordan Valley Innovation Center
A record $6.2 million grant has been awarded to Misorui State University's Jordan Valley Innovation Center and its corporate partners Nantero Inc. (Woburn, Mass.) and Carbon Nanotechnologies Inc. (Houston, Texas) to develop carbon-based satellite components. The award is from the Office of Naval Research for components — high-speed processing and control elements, specifically — that will be able ... (Tue, 27 Feb 2007 18:24:49 GMT)

Rosetta Genomics Begins Trading on Nasdaq
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 27 Feb 2007 20:36:32 GMT)

LLNL researchers review bio detection technologies
LIVERMORE, Calif. – In an effort to detect biological threats quickly and accurately, a number of detection technologies have been developed. (Tue, 27 Feb 2007 22:27:44 GMT)

News: The Science of Getting It Wrong: How to Deal with False Research Findings
FALSE POSITIVES: Researchers poring over their samples for novel results may be contributing to a flood of false research results. Tighter collaboration between investigators may be one way to reduce such errors. (Wed, 28 Feb 2007 05:21:18 GMT)

Biotech Day in Review: Biotech Takes a 3% Hit
Centient Biotech Investor submits: Biotech followed the broad market lower on Tuesday, after the Shanghai stock exchange fell 9%. In China, there were reports that the government would try to slow speculation by clamping down on lending money to buy stocks. (Wed, 28 Feb 2007 06:49:08 GMT)

Her sister's murder
WOODS CROSS -- Investigators are hoping that evidence found under the fingernails of Karin Strom's dead body 27 years ago will lead them to her murderer. (Wed, 28 Feb 2007 07:32:52 GMT)

Lexicon Genetics Elects Kathleen Wiltsey to Board of Directors
Lexicon Genetics Incorporated announced today that Kathleen Wiltsey has been elected to its board of directors. (Wed, 28 Feb 2007 11:30:00 GMT)

Applied Biosystems/MDS SCIEX's Software Development Initiative Targets Drug Discovery with Rapid Analysis of Compounds
FOSTER CITY, Calif.----Applied Biosystems , an Applera Corporation business, and its joint venture partner, MDS Sciex, a division of MDS Inc. , today announced a new software development initiative to improve the abilities of pharmaceutical companies to determine drug candidate viability early in the development pipeline. (Wed, 28 Feb 2007 12:00:00 GMT)

Alnylam Scientist Awarded Two Industry Honors
CAMBRIDGE, Mass.----Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that Dr. Rachel Meyers, Director of Research at Alnylam, has been recognized with two industry honors. (Wed, 28 Feb 2007 13:00:00 GMT)

Nanogen Awarded Patents for Biomarkers Associated with Diabetes, Alzheimers Disease
SAN DIEGO----Nanogen, Inc. , developer of advanced diagnostic products, announced today that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimers disease biomarkers. (Wed, 28 Feb 2007 13:00:00 GMT)

Researchers Review New Technologies For Detecting Biological Threats
In an effort to detect biological threats quickly and accurately, a number of new detection technologies have been developed. (Wed, 28 Feb 2007 13:12:08 GMT)

Uniform language for describing genes of pathogenic and beneficial microbes
Blacksburg, Va., February 28, 2007 – An international group of scientists has announced a major expansion of a lingua franca used to describe the activities of genes in living organisms. (Wed, 28 Feb 2007 13:12:31 GMT)

BioReference Laboratories Announces New Horizon Blue Cross Blue Shield of New Jersey Ancillary Services Arrangement
ELMWOOD PARK, N.J.----BioReference Laboratories, Inc. announced today that it has reached an accord with Horizon Blue Cross Blue Shield of New Jersey to enable it to remain in the Horizon BCBSNJ PPO network. (Wed, 28 Feb 2007 13:30:00 GMT)

Rhode Island Biotechnology Company Receives $ 368K Federal Grant to Reengineer Botulinum Toxin Using ...
PROVIDENCE, R.I.----EpiVax, Inc, a leader in genome-derived vaccines, announced today that it has received a grant to reengineer botulinum toxin, a protein that is used for cosmetic purposes and which is also used as a revolutionary therapeutic for movement disorders categorized as "dystonias" such as Parkinson's Disease and Cerebral Palsy. (Wed, 28 Feb 2007 15:09:00 GMT)

Language created for describing genes
A U.S.-led international group of scientists has expanded a lingua franca used to describe the activities of genes in living organisms. The expansion is ... (Wed, 28 Feb 2007 16:40:34 GMT)

OncoGenex Technologies Postpones IPO
Biotechnology company OncoGenex Technologies Inc. postponed its initial public offering because of market conditions, analysts said Wednesday. (Wed, 28 Feb 2007 16:46:27 GMT)

Nanogen Awarded Patents for Biomarkers Associated With Diabetes, Alzheimers Disease
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimers disease biomarkers. (Wed, 28 Feb 2007 18:49:41 GMT)

Applied Biosystems and Celera to Webcast Investor Meetings
FOSTER CITY, Calif. & ALAMEDA, Calif.----Applied Biosystems Group and Celera Group , Applera Corporation businesses, will webcast meetings with investors to be held at Celera's offices in Alameda, California on March 7, 2007. (Wed, 28 Feb 2007 21:05:00 GMT)

Schering-Plough Announces Executive Changes in Research
Schering-Plough Corporation today announced the appointment of Ismail Kola, Ph.D., as senior vice president, Discovery Research, in Schering-Plough Research Institute , and as the company's Chief Scientific Officer. (Wed, 28 Feb 2007 21:44:00 GMT)

Integrated Genomics Files Suit to Defend Intellectual Property
CHICAGO----Integrated Genomics , a leading microbial genomics company, today announced that it has filed a lawsuit against two former employees for breach of their employment contracts with IG, including breach of their non-competition and non-solicitation obligations. (Wed, 28 Feb 2007 23:03:00 GMT)

Previous 1 2 3 4